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Summary
 
To elucidate the function of the mouse TL antigen in the thymus, we have derived two TL
transgenic mouse strains by introducing 
 
Tla
 
a
 
-3
 
 of A strain origin with its own promoter onto a
C3H background with no expression of TL in the thymus. These transgenic mouse strains,
both of which express high levels of Tla
 
a
 
-3-TL antigen in their thymus, were analyzed for their T
cell function with emphasis on cytotoxic T lymphocyte (CTL) generation. A T cell response
against TL was induced in Tg.Tla
 
a
 
-3-1, Tg.Tla
 
a
 
-3-2, and control C3H mice by skin grafts from
 
H-2K
 
b
 
/
 
T3
 
b
 
 transgenic mice, Tg.Con.3-1, expressing T3
 
b
 
-TL ubiquitously. Spleen cells from
mice that had rejected the T3
 
b
 
-TL positive skin grafts were restimulated in vitro with
Tg.Con.3-1 irradiated spleen cells. In mixed lymphocyte cultures (MLC), approximately 20%
and 15% of Thy-1
 
1
 
 T cells derived from Tg.Tla
 
a
 
-3-1 and Tg.Tla
 
a
 
-3-2, respectively, expressed
TCR
 
gd
 
, whereas almost all those from C3H expressed TCR
 
ab
 
. The MLC from Tg.Tla
 
a
 
-3-2
and C3H demonstrated high CTL activity against TL, while those from Tg.Tla
 
a
 
-3-1 had little
or none. The generation of 
 
gd
 
 CTL recognizing TL in Tg.Tla
 
a
 
-3-2, but not C3H mice, was
confirmed by the establishment of CTL clones. A total of 14 
 
gd
 
 CTL clones were established
from Tg.Tla
 
a
 
-3-2, whereas none were obtained from C3H. Of the 14 
 
gd
 
 CTL clones, 8 were
CD8
 
1
 
 and 6 were CD4
 
2
 
CD8
 
2
 
 double negative. The CTL activity of all these clones was TL
specific and inhibited by anti-TL, but not by anti-H-2 antibodies, demonstrating that they rec-
ognize TL directly without antigen presentation by H-2. The CTL activity was blocked by an-
tibodies to TCR
 
gd
 
 and CD3, and also by antibodies to CD8
 
a
 
 and CD8
 
b
 
 in CD8
 
1
 
 clones,
showing that the activity was mediated by TCR
 
gd
 
 and coreceptors. The thymic origin of these
 
gd
 
 CTL clones was indicated by the expression of Thy-1 and Ly-1 (CD5), and also CD8
 
ab
 
heterodimers in CD8
 
1
 
 clones on their surfaces and by the usage of TCR V
 
g
 
4 chains in 12 of
the 14 clones. Taken together, these results suggest that Tla
 
a
 
-3-TL antigen expressed in the
thymus engages in positive selection of a sizable population of 
 
gd
 
 T cells.
 
M
 
ice have at least 30–40 genes called “nonclassical”
MHC class I or MHC class “Ib” genes mainly map-
ping to three chromosomal regions within the murine
MHC: H-2Q, T, and M (1, 2). Recent studies have dem-
onstrated that some of the proteins encoded by these genes
are related to the classical MHC class I molecules in struc-
ture and in function, presenting antigens to 
 
ab
 
 or 
 
gd
 
 T cells
(reviewed in reference 2), while others have completely
different functions such as that acting as an Fc receptor for
IgG (FcRn) (3). The idea that some nonclassical class I
molecules might function as restriction elements for 
 
gd
 
 T cells
has been suggested by the distinctive tissue distribution and
limited V gene usage of 
 
gd
 
 T cells. Indeed, several studies
have shown that 
 
gd
 
 T cells recognize nonclassical class I
molecules encoded by genes located within the Q or T re-
gions (reviewed in references 4, 5).
TL antigens belong to the family of nonclassical MHC
class I antigens (6). At least one gene coding for a TL anti-
gen is present in all mouse strains so far tested, and two or
more have been found in some strains; 
 
T3
 
b
 
 has been found
in C57BL/6 (B6)
 
1
 
, 
 
T3
 
k
 
 in C3H/He (C3H), 
 
T3
 
d
 
 and 
 
T18
 
d
 
in BALB/c and 
 
Tla
 
a
 
-1
 
, 
 
Tla
 
a
 
-2
 
 and 
 
Tla
 
a
 
-3
 
 in A strain. What
makes TL distinct from other MHC class I antigens is their
unique expression profile (6–10). TL antigens are expressed
in epithelial cells of the small and large intestines in all
mouse strains. Certain strains such as A and BALB/c also
 
1
 
Abbreviations used in this paper:
 
 B6, C57BL/6; C3H, C3H/He; cAb, con-
ventional antibody; DN, CD4
 
2
 
CD8
 
2
 
 double negative; Ltk
 
2
 
, thymidine
kinase-negative L cell; MFI, mean fluorescence intensity; PBR, peptide
binding region; RT, reverse transcription.
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express TL on normal thymocytes, while others such as B6
and C3H do not. Even in B6 and C3H mice, however,
malignant transformation of T cell causes TL to be ex-
pressed.
The structures of TL genes and products are very similar
to those of classical MHC class I genes and products (6).
However, until our recent study, TL had not been shown
to behave like MHC class I antigens in terms of histocom-
patibility antigen. We derived 
 
H-2K
 
b
 
/
 
T3
 
b
 
 transgenic mice
expressing the TL antigen ubiquitously under the action of
an 
 
H-2K
 
b
 
 promoter (11). By transplanting their skin onto
C3H mice, the background strain, we demonstrated that
TL can serve as a transplantation antigen and elicit TCR
 
ab
 
CD8
 
1
 
 CTL response (12). Furthermore, we showed that
this CTL response is TL restricted so that CTL directly rec-
ognizes TL or a complex of TL plus antigenic molecules
without any requirement for antigen presentation by classi-
cal MHC class I molecules. The results suggested the possi-
bility that TL can serve as an antigen presenting molecule,
similar to classical MHC class I antigens.
We have derived another pair of transgenic mouse strains
with 
 
Tla
 
a
 
-3
 
 of A strain origin. One of these, Tg.Tla
 
a
 
-3-1,
expresses large amounts of TL antigen on thymocytes and
has a small thymus consisting mainly of L3T4(CD4)
 
2
 
Lyt-
2(CD8)
 
2
 
 double negative (DN) cells of 
 
gd
 
 lineage, and it
develops a high incidence of T cell lymphomas, suggesting
that TL plays a critical role in T cell development in the
thymus, especially of the 
 
gd
 
 T cell lineage (13). However,
the other 
 
Tla
 
a
 
-3
 
 transgenic strain, Tg.Tla
 
a
 
-3-2, demon-
strates no obvious abnormalities in thymic development
and does not develop T cell lymphomas (11). In the
present study, to define the role of TL antigens expressed in
the thymus, we generated and characterized TL-restricted
CTL responses in Tg.Tla
 
a
 
-3-1 and Tg.Tla
 
a
 
-3-2 mice and
made a comparison with those in C3H strain.
 
Materials and Methods
 
TL Genes.
 
Three TL genes, 
 
T3
 
b
 
 of B6 (14), 
 
Tla
 
a
 
-3
 
 of A strain
(15), and 
 
T3
 
k
 
 of C3H (EMBL/GenBank/DDBJ accession No.
D86082) were involved in this study. The DNA sequences of
their coding regions and deduced amino acid sequences are very
similar to each other and 
 
.
 
90% of their nucleotides and amino
acids are identical. Furthermore, all three TL molecules have
identical amino acid sequences in the putative peptide binding re-
gion (PBR) which determines the binding specificity of MHC
class I molecules to antigenic peptides and to TCR. Outside
PBR, however, there are differences as shown in Fig. 1.
 
Mice.
 
The derivation of transgenic mouse strains has been de-
scribed previously (11). Briefly, a pair of transgenic strains,
Tg.Con.3-1 and Tg.Con.3-2, were produced by introducing a
chimeric gene consisting of the 
 
H-2K
 
b
 
 promoter region and exon
1 (encoding the signal peptide) and the 
 
T3
 
b
 
 exons 2–6 (encoding
the mature protein). These mice express T3
 
b
 
-TL in almost all tis-
sues including their skins and spleens. The other pair, Tg.Tla
 
a
 
-3-1
and Tg.Tla
 
a
 
-3-2, having a 
 
Tla
 
a
 
-3
 
 transgene with its own pro-
moter from A strain, express Tla
 
a
 
-3-TL predominantly on thy-
mocytes. All transgenic mice were generated on a C3H background
which does not express TL in the thymus. C3H mice were pur-
chased from Japan SLC Inc. (Hamamatsu, Shizuoka, Japan).
 
Antibodies.
 
The following mAbs and one conventional anti-
body (cAb) were developed in our laboratory, provided by vari-
ous scientists, or purchased: Rat mAb to Lyt-2 (53-6.7; Dr. N.
Shinohara, Mitsubishi Kasei Institute for Life Science, Machida,
Japan [16]), rat mAb to L3T4 (GK1.5; Dr. N. Shinohara [17]),
hamster mAb to TCR
 
ab
 
 (H57-597; Dr. R.T. Kubo, National
Jewish Center for Immunology and Respiratory Medicine, Den-
ver, CO [18]), hamster mAb to TCR
 
d
 
 (3A10; Dr. S. Tonegawa,
Massachusetts Institute of Technology, Cambridge, MA [19]),
hamster mAb to TCR
 
gd
 
 (GL3; Cedarlane Labs. Ltd., Hornby,
Ontario, Canada), hamster mAb to Vg4 (UC3-10A6; PharMin-
gen, San Diego, CA), hamster mAb to CD3 (145-2C11; Dr. J.A.
Bluestone, The University of Chicago, Chicago, IL [20]), mouse
mAb to TL.2 (TT213 [12]), mouse mAb to Ly-1.1, mouse mAb
to Lyt-3.2 (ID9P35), rat mAb to Thy-1.2 (Becton Dickinson,
Immunocytometry Sys., Mountain View, CA), and cAb to H-2k
([B6 3 DBA/2] anti-C3H mammary tumor, MM48).
Flow Cytometric Analysis. Flow cytometric analysis was per-
formed with a FACScanÒ. For secondary reagents, PE-conjugated
streptavidin (Biomeda Corp., Foster City, CA), FITC-labeled anti–
hamster Ig (CALTAG Labs., South San Francisco, CA), anti–rat
Ig (Tago Inc., Burlingame, CA), or anti–mouse Ig (DAKO-
PATTS, Glostrup, Denmark) were used.
Skin Grafts. Female Tg.Tlaa-3-1, Tg.Tlaa-3-2 and C3H mice
(6–10-wk-old) received full-thickness sections of skin (1-cm
disks) from the abdomens of Tg.Con.3-1 mice onto their backs.
Plaster casts were removed on day 10.
Establishment and Maintenance of CTL Bulk Cultures and Clones.
The methods for induction of CTL and assays for their cytotoxic
activity have been described previously (12). Briefly, 4–8 wk after
the rejection of grafted skin, spleen cells (5 3 107) from the recip-
ient mice were cultured with 5 3 107 irradiated (2,000 R)
Tg.Con.3-1 spleen cells for 5 d. The cells were used as effector
Figure 1. Comparison of the predicted amino acid sequences of TL
molecules of Tlaa-3 of A mice, T3b of B6, and T3k of C3H. Only amino
acid residues different among the three TL molecules are shown. Amino
acid sequences are given by the single-letter code, and amino acid num-
bers in the mature peptide are noted above the sequences.2177 Tsujimura et al.
cells in CTL assays and maintained as CTL bulk cultures by
weekly restimulation with irradiated Tg.Con.3-1 spleen cells in
the presence of human recombinant IL-2 (Takeda Chemical In-
dustries Ltd., Osaka, Japan) at a concentration of 5 ng/ml. For
CTL assays, 51Cr-labeled target cells (2 3 104) were incubated
with various numbers of effector cells. For the blocking test of
CTL activity by antibodies, serially diluted antibodies were added
to mixtures of effector cells and labeled target cells. After incuba-
tion for 3 h at 378C, the supernatants were harvested using a Su-
pernatant Collection System (Skatron Inc., Sterling, VA) for mea-
surement of 51Cr release. The percent specific lysis was calculated
using the following equation: 100 3 (a 2 b/c 2 b), where a is the
radioactivity in the supernatant of target cells mixed with effector
cells, b is the radioactivity in the supernatant of target cells incu-
bated without effector cells, and c is the radioactivity in the super-
natant after complete lysis of target cells with 2% Triton X-100.
For cloning, cells were diluted to 1–100 cells/well and cul-
tured with irradiated Tg.Con.3-1 spleen cells in the presence of
IL-2 in 96-well plates. After 10–14 d, the cytotoxity of clonally
growing cells was tested. Established clones were maintained by
weekly stimulation and their activity was tested as described
above.
Target Cells. Con A–stimulated spleen cells of Tg.Con.3-1
and C3H were prepared as previously described (12). In addition
to Con A–stimulated spleen cells, the following cells were used as
targets for CTL assays, with the amounts of TL gene product on cell
surfaces were estimated by flow cytometry with TT213 anti-TL
mAb: Con A blasts of Tg.Con.3-1 (mean fluorescence intensity
[MFI] of stained cells - MFI of unstained cells; 298.6, expressing
T3b), C3H (0.1, TL2) and B6 (1.5, TL2), thymidine kinase-neg-
ative L-cells ([Ltk2], 4.0, TL2), and H-2Kb/T3b Ltk2 transfec-
tants (785.0, T3b), as well as ERLD (derived from B6, 253.5,
T3b), RADA1 (derived from A strain, 178.9, Tlaa-1, -2, and -3),
and ASL-1 (derived from A strain, 584.1, Tlaa-1, -2, and -3) leu-
kemias maintained in vivo.
RNA Extraction and Reverse Transcription–PCR. Total RNA
was extracted from CTL clones using TRIzol Reagent (GIBCO
BRL, Gaitherburg, MD). 10 mg of total RNA were reverse tran-
scribed into first strand cDNA with 3 mg of random primers and
1,000 U of SuperScript II reverse transcriptase (RT) (GIBCO
Figure 2. Experimental design
for testing the characteristics of
anti-TL CTL generated in Tlaa-3
transgenic and C3H mice. The
skins obtained from Tg.Con.3-1
mice expressing T3b-TL antigen
were grafted onto Tg.Tlaa-3-1
and Tg.Tlaa-3-2 transgenic and
C3H mice. Tg.Tlaa-3-1 and
Tg.Tlaa-3-2 mice express Tlaa-
3-TL encoded by the transgene
in the thymus and in the intes-
tines as well as endogenous T3k-
TL in the intestines, while C3H
mice express T3k-TL in the in-
testines, but not in the thymus.
CTL were generated by MLC,
in which spleen cells of mice that
had rejected the skin graft were
restimulated with irradiated
Tg.Con.3-1 spleen cells.
Figure 3. Surface antigen profiles of the TL-reac-
tive cells obtained from bulk MLC. Spleen cells
from Tg.Tlaa-3-2, Tg.Tlaa-3-1, and C3H that had
rejected Tg.Con.3-1 skin grafts were cultured with
irradiated spleen cells from Tg.Con.3-1. After 5 d
in culture, the cells were double-stained with various
combinations of antibodies, and the blastic cell popu-
lation was gated and analyzed with a FACScanÒ.
(A) Expression of TCR/CD3 complexes on Thy-11
cells in bulk MLC. About 80, 25, and 80% of the
gated cells derived from Tg.Tlaa-3-2, Tg.Tlaa-3-1,
and C3H, respectively, expressed Thy-1 on their
surfaces. The percentages of cells expressing CD3,
TCRab, and TCRgd among Thy-11 cells are
indicated. (B) Expression of L3T4 and Lyt-2 on
TL-reactive  gd T cells obtained from Tg.Tlaa-3-2.2178 Positive Selection of gd CTL by TL Antigen
BRL). TCRg chains were amplified using Vg-specific primers
and a single common Cg primer by the methods of Takagaki
(21). The nomenclature of Vg is according to Reilly et al. (22).
The RT-PCR products were separated by agarose gel electro-
phoresis.
Nucleotide Sequencing of the Vg-Jg Junction. PCR products were
cloned into a T-tailed M13mp18 vector and sequenced by a cycle
sequencing method using an automated DNA sequencer (model
373A; Applied Biosystems, Inc., Foster City, CA).
Results
Characteristics of Anti–T3b-TL CTL Generated in Transgenic
Mice Expressing Tlaa-3-TL Antigen in the Thymus. To inves-
tigate the role of TL antigen expressed in the thymus, a T
cell response against TL was induced by transplanting T3b-
TL positive skin of Tg.Con.3-1 onto Tg.Tlaa-3-1 and
Tg.Tlaa-3-2 mice, two transgenic strains expressing Tlaa-
3-TL in the thymus, and also onto C3H mice without thy-
mic TL expression (Fig. 2). All three strains rejected the
grafted skin within 3 wk, in accordance with our previous
data (12). The spleen cells from mice which had rejected
Tg.Con.3-1 skin were restimulated in vitro with irradiated
T3b-TL1 spleen cells from Tg.Con.3-1. Spleen cells of
Tg.Tlaa-3-2 and C3H reacted vigorously and about 80%
were found to be blastic cells expressing Thy-1 and CD3
on their surfaces. In contrast, Tg.Tlaa-3-1 reacted weakly
and only 25% were Thy-11CD31 blastic cells. (Fig. 3 A).
Of the Thy-11 T cells, almost all of those derived from
C3H expressed TCRab, while z15% from Tg.Tlaa-3-2
and .20% from Tg.Tlaa-3-1 expressed TCRgd. In the gd
T cell population derived from Tg.Tlaa-3-2, two thirds
were L3T42Lyt-21, while approximately one third were
L3T42Lyt-22 double negative (DN), and very few were
L3T41Lyt-22 (Fig. 3 B). Of the gd T cells from Tg.Tlaa-3-1,
z60% were DN, 25% were L3T42Lyt-21, and 15% were
L3T41Lyt-22 (data not shown). In the ab T cell popula-
tion derived from both Tg.Tlaa-3-2 and C3H, .70% were
L3T42Lyt-21 and the rest were L3T41Lyt-22. In contrast,
the ab T cell population from Tg.Tlaa-3-1 consisted of
z45% L3T42Lyt-21, 45% L3T41Lyt-22 and 10% DN
cells (data not shown).
The in vitro stimulated T cells were tested for cytotoxic
activity against TL1 targets. T cells from Tg.Tlaa-3-2 and
C3H showed high levels of CTL activity against TL1 target
cells, but not TL2 cells (Fig. 4 A). Tg.Tlaa-3-1, however,
yielded little or no CTL activity (data not shown), con-
firming the previous finding that the T cell function of
Tg.Tlaa-3-1 is severely impaired (13). Therefore, in the
subsequent studies, only CTL from Tg.Tlaa-3-2 and C3H
were characterized. The CTL activity of Tg.Tlaa-3-2
against various target cells was not different from that of
C3H which has been previously described (12). As shown
in Fig. 4 B, the CTL activity from both was blocked by
anti-TL antibody, but not by anti-H-2k, thus confirming
that CTL recognizes TL directly without involving anti-
genic presentation by H-2 (12). The CTL activity of C3H
was also blocked by anti-TCRab, CD3, and Lyt-2 anti-
bodies but not by anti-TCRgd or anti-L3T4. In the
Tg.Tlaa-3-2 case, the CTL activity was blocked partially by
anti-TCRgd antibody, although not as strongly as shown
by anti-TCRab antibody, indicating a certain population
of gd T cells. Together with the data from flow cytometric
analysis, these results suggested that a small but significant
proportion of CTL recognizing T3b-TL was skewed to-
Figure 4. Specificity of the TL-reactive CTL populations in bulk cul-
tures derived from Tg.Tlaa-3-2 and C3H. (A) Generation of CTL against
TL antigen in Tg.Tlaa-3-2 and C3H. The effector cells were prepared
from Tg.Tlaa-3-2 and C3H mice that had rejected Tg.Con.3-1 skin
grafts. Target cells were T3b-TL1 blast cells of Tg.Con.3-1 (d) and TL2
blast cells of C3H (s), H-2Kb/T3b Ltk2 transfectants (j), Ltk2 ( h ),
ERLD (m), RADA1 (n), and ASL1 (,). For TL expression on these tar-
get cells, see Materials and Methods. (B) Antibody blocking for character-
ization of the CTL populations from Tg.Tlaa-3-2 and C3H. The cyto-
toxic activity of CTL generated in Tg.Tlaa-3-2 and C3H by grafting
Tg.Con.3-1 skin was tested in the presence of mAbs to TL.2 (TT213)
(h), TCRab (s), TCRgd (d), CD3 (g), L3T4 (.), Lyt-2 (m), or cAb
to H-2k (j). The broken lines indicate the percentage specific lysis ob-
tained without antibodies. The target cells were Con A blast cells of
Tg.Con.3-1 and E/T ratio was 15:1.2179 Tsujimura et al.
ward the gd lineage by the presence of Tlaa-3-TL antigen
in the thymus.
Establishment of gd CTL Clones. To examine further the
influence of TL antigen expressed in the thymus on the
CTL population, TL-reactive CTL clones were established
from Tg.Tlaa-3-2 and C3H. 23 clones were initially de-
rived from four Tg.Tlaa-3-2 mice and the same number
from three C3H mice. By flow cytometric and antibody
blocking analyses, 3 out of the 23 CTL clones derived from
Tg.Tlaa-3-2 mice were found to express TCRgd, whereas
all C3H CTL clones expressed TCRab. Thus, establish-
ment of the CTL clones indicated that gd CTL are induced
characteristically in mice expressing TL in their thymus,
confirming the results of bulk cultures.
Characteristics of the gd CTL Clones. The three gd CTL
clones described above were all Lyt-21 (see below), al-
though one third of gd T cells in bulk culture were DN as
shown in Fig. 3 B. To test whether TL-reactive gd CTL
clones with DN phenotype could be established, 11 addi-
tional gd CTL clones were derived from five Tg.Tlaa-3-2
mice. Thus, a total of 14 gd CTL clones were character-
ized, as summarized in Table 1. Flow cytometric analysis
showed eight to be Lyt-21 and six to be DN. Lyt-2 is a
CD8a chain, and in T cells of thymic origin, it forms a
heterodimer with Lyt-3, a CD8b chain, while it forms an
aa homodimer in those of intestinal epithelium (23). All
Lyt-21 gd CTL clones established in this study also ex-
pressed Lyt-3, indicating a thymic origin. In addition, a
thymic origin of not only Lyt-21, but also DN gd CTL
clones, was indicated by the fact that all clones expressed
Thy-1 and Ly-1 (CD5) on their cell surface (Table 1). Both
antigens have been shown to be expressed on gd T cells
of thymic origin, but not on those of extra-thymic origin
(24, 25).
The 14 gd clones were examined for their cytotoxic ac-
tivity against TL1 and TL2 target cells. All lysed TL1 target
cells including Con A blasts of Tg.Con.3-1 and RADA1,
but not TL2 cells including Con A blasts of C3H and B6.
The results with CTL clones were essentially identical to
those with the bulk culture. The gd CTL clones were also
tested by antibody blocking for their target specificity and
the expression of TCR and coreceptor molecules. The re-
sults are summarized in Table 1 and representative findings
are shown in Fig. 5. Fig. 5, A and C, illustrate results for one
of the Lyt-21 gd CTL clones, KC4-4, and Fig. 5, B and D,
for one of the DN gd CTL clones, KC8-3. The CTL ac-
tivity of all these gd CTL clones was blocked by anti-TL
antibodies, indicating the TL-specific CTL activity. Blocking
by anti-TL antibodies but not by anti–H-2k antibody fur-
ther indicated that these gd CTL clones directly recognize
the TL molecule. The CTL activity was also blocked by
anti-TCRgd and CD3 antibodies. All Lyt-21 gd CTL
clones were blocked by anti–Lyt-2 and anti–Lyt-3 antibod-
ies while all DN clones were not, confirming the results of
Table 1. Summary of gd CTL Clones
Clone*
Vg usage
(RT-PCR)
gdTCR expression§ Surface antigens (FACSÒ) Blocking of the cytotoxicity with antibody¶
TCRgd TCRd Vg4 CD4/CD8i Thy-1 Ly-1 TL H-2 TCRd** Lyt-2 Lyt-3 L3T4
KC1-3 1/2‡ 11 2 CD8a b 1 1 1 2 1 112
1-7 4‡ 11 1 CD8a b 1 1 1 2 1 112
4-4 2/4‡ 11 1 CD8a b 1 1 1 2 1 112
4-8 1/2/4‡ 11 1 DN 1 1 1 2 1 222
4-9 2/4 11 1 CD8a b 1 1 1 2 1 112
5-1 2/4 11 1 CD8a b 1 1 1 2 1 112
5-2 2/4 11 1 CD8a b 1 1 1 2 1 112
6-1 2/4‡ 11 1 DN 1 1 1 2 1 222
6-2 2/4 11 1 CD8a b 1 1 1 2 1 112
7-3 1/2/4 11 1 CD8a b 1 1 1 2 1 112
7-4 1/2‡ 11 2 DN 1 1 1 2 1 222
8-1 2/4 11 1 DN 1 1 1 2 1 222
8-3 2/4‡ 11 1 DN 1 1 1 2 1 222
8-4 2/4 11 1 DN 1 1 1 2 1 222
* The first digit of the clone name shows the origin of the mouse.
‡RT-PCR products were sequenced (see Fig. 6).
§Expression of TCRgd, TCRd, and Vg4 chains on the cell surface were detected by FACSÒ using moAb GL3, 3A10, and UC3-10A6, respectively.
iMonoclonal antibodies to L3T4, Lyt-2 and Lyt-3 were used.
¶The target cells were Con A blasts of spleen cells from Tg.Con.3-1 (T3b-TL positive).
**Monoclonal antibody 3A10 was used.2180 Positive Selection of gd CTL by TL Antigen
flow cytometric analysis. Other than the Lyt-2 and Lyt-3
expression, these 14 gd CTL clones showed no differences
in their expression of adhesion, costimulatory, and acces-
sory molecules; all gd CTL clones were positive for Pgp-1
(CD44), LFA-1 (CD11a), ICAM-1 (CD54), CD2, CD28,
CTLA-4, and IL-2Ra/b, and negative for L-selectin
(CD62L), VLA-4a (CD49d), and HSA (data not shown).
To further confirm the thymic origin of these gd CTL
clones, their Vg segment usage was determined. By RT-
PCR, nine clones yielded Vg2 and Vg4 products, two
clones Vg1 and Vg2, two clones Vg1, Vg2 and Vg4, and
one clone Vg4, while no clones yielded Vg5, Vg6, or Vg7
products (Table 1). There was no distinctive difference in
the usage of Vg by Lyt-21 clones from that by DN clones.
All of 12 clones with RT-PCR Vg4 products reacted with
an antibody specific to Vg4 in the flow cytometric analysis,
indicating that Vg4 chains were indeed expressed on the
cell surface. It has been reported that the Vg4 chain is pref-
erentially used by thymus-dependent gd T cells, while Vg1
and Vg2 chains are used by both thymus-dependent and
-independent gd T cells (26, 27). Thus, the results indi-
cated that most, if not all, of these clones were derived from
adult thymus. To determine the diversity in the CDR3
region of g chains, RT-PCR products from seven repre-
sentative clones, three Lyt-21 and four DN, were sequenced
(Fig. 6). One or two in-frame products were identified and
they contained N region nucleotides at all the V–J junc-
tions except for Vg2 and Vg4 chains in KC1-3 and KC4-8,
respectively. The deduced amino acid sequences for the
CDR3 were different from one another except for those of
the Vg2 chains in the KC6-1 and KC7-4 clones, suggest-
ing that a diverse set of gd TCR recognize the TL mole-
cule. In summary, the usage of Vg4 chains with N se-
quences in 12 of 14 clones, and the expression of Thy-1,
Ly-1, and CD8ab heterodimer in the case of Lyt-21 clones,
indicated that these gd CTL clones that recognize TL were
matured in adult thymus.
Discussion
The present study on the role of TL antigen expressed in
the thymus on T cell selection demonstrated that a sizable
population of CTL recognizing T3b-TL induced in Tlaa-3-2
transgenic mice are gd T cells, in contrast to those in C3H
mice which were found to be mostly ab T cells. Most of
the gd CTL were of adult thymic origin; all of them ex-
pressed Thy-1, Ly-1 (CD5) and CD8ab heterodimers in
the cases of Lyt-21 clones, and 12 of 14 clones used TCR
Vg4 chains with N sequences in the V–J junctions except
for Vg4 of KC4-8. Thus, our results indicate that the pres-
ence of Tlaa-3-TL in the thymus promotes the positive se-
lection of gd T cells recognizing T3b-TL. T3b and Tlaa-3
have identical amino acids in the putative PBR which de-
termine the binding specificity to antigenic peptides and to
TCR. Therefore, it is most likely that gd T cells, selected
on the basis of their affinity for Tlaa-3, are able to react
with T3b as well, and that such gd T cells are stimulated to
generate CTL against T3b by T3b1 skin grafts. Thus, the
presence of TL molecules in the thymus is required for the
selection of gd T cells reactive to TL, and cannot be substi-
tuted for by any other MHC class I or CD1 molecules ex-
pressed in C3H mice. This notion is supported by the ex-
pansion of gd T cells in the thymus and periphery of the
other transgenic mouse strain, Tg.Tlaa-3-1, as we reported
previously (13). An association of TL antigen with gd T cells
has also been speculated from the observation that it is ex-
pressed in the intestinal epithelium and gd T cells are
Figure 5. Specificity of two representatives of Lyt-21 and DN gd CTL
clones. (A and B) Target specificity of Lyt-21 KC4-4, and DN KC8-3 gd
CTL clones against TL. Target cells were Con A blast cells of Tg.Con.3-1
(d), C3H (s) and B6 (g), H-2Kb/T3b Ltk2 transfectants (j), Ltk2 (h),
and RADA1 (n). For TL expression on these target cells, see Materials
and Methods. (C and D) Antibody blocking for characterization of Lyt-21
KC4-4 and DN KC8-3 gd CTL clones. The cytotoxic activity of gd
CTL clones was tested in the presence of mAb to TL.2 (TT213)(h),
TCRab (s), TCRgd (d) , CD3 (g), L3T4 (.), Lyt-2 (m), Lyt-3 (n),
or cAb to H-2k (j). The target cells were Con A blast cells of Tg.Con.3-1
and E/T was 5:1.2181 Tsujimura et al.
present nearby (9, 10), although no direct evidence for any
interaction between the intestinal epithelium and gd T cells
has been presented.
It is an intriguing question whether normal mice that ex-
press TL in the thymus also produce gd CTL with specific-
ity for TL. However, they do have at least two, and as
many as four, TL genes (6, 31) which are expressed simul-
taneously in the thymus at levels which differ from strain to
strain. Therefore, it will be a very difficult task to deter-
mine which TL genes are responsible for T3b-specific re-
sponses and for selection of gd CTL. Although two TL
congenic strains, B6-TL1 and A-TL2 are available, it is
known that they are different from their counterparts, B6
and A, not only in terms of their TL genes but also for as
many as 20 other MHC class I genes located in the TL re-
gion (32). Some of these class I genes have very similar
structures and expression patterns to TL genes (10, 32), and
some have been shown to cause skin graft rejection (33).
Accordingly, it will be very difficult to rule out their in-
volvement in TL recognition. To unravel the complexity
of the TL system, we have generated and analyzed trans-
genic mice with Tlaa-3 gene driven by its own promoter as
a first step. A definite answer can only be obtained from the
analysis of transgenic mice with other TL genes, such as
Tlaa-1, Tlaa-2 and T18d, which are currently under con-
struction.
Regarding the specificity, the finding that both bulk and
cloned gd CTL were cytotoxic against Tlaa-3-expressing
RADA1 suggested that they may be auto-reactive. RADA1,
however, expresses at least two other TL genes, in addition
to Tlaa-3 (6). Thus, there remains a possibility that the reac-
tivity is directed against antigens encoded by TL genes
other than Tlaa-3. To clarify this point, target cells express-
ing only Tlaa-3 are needed. Transfection experiments to
this end are now underway. Only after they are concluded
and modes of recognition of TL molecules by CTL are
elucidated (see below), will we be in a position to answer
the questions of whether and how the negative selection
operates against Tlaa-3 in the thymus.
The majority of gd T cells in mice and humans and most
gd T cell clones or hybridomas reported so far do not ex-
press either CD4 or CD8 (4, 5). This suggests that gd T cells
recognize MHC or non-MHC molecules with low or no
affinity to CD4 or CD8 coreceptors, or that the maturation
and activation of gd T cells do not require the presence of
CD4 or CD8 molecules. Since there have hitherto been
only few reports of gd T cell clones with clear CTL or
helper activity, it has been difficult to conduct detailed
studies on the requirement of coreceptors for gd T cells.
Our present finding that 8 of 14 TL-restricted gd CTL
clones express CD8ab, supports the proposal that TL can
bind CD8 (34) and further implies that the CD8-p56lck sig-
nal pathway can operate in gd CTL, similarly to the ab
CTL case (35). In addition to CD81 gd CTL, DN gd CTL
clones were also established. Analysis of DN gd CTL clones
has so far shown no differences from CD81 gd CTL clones
in their cytotoxic specificity or activity, or in the expres-
sion of costimulatory or adhesion molecules except CD8.
Figure 6. Nucleotide sequences of
the V-J junction of TCRg-genes ex-
pressed in gd CTL clones. RNA was
extracted from gd CTL clones and
RT-PCR was carried out. Sequencing
of the RT-PCR products was con-
ducted as described in Materials and
Methods. For each sequence, the N
nucleotides were deduced from the
germline sequence previously reported
(26–30). The nomenclature of Vg seg-
ments is according to Reilly et al. (22).2182 Positive Selection of gd CTL by TL Antigen
The differential expression of CD8 in these gd CTL may
be due to the affinity of TCR for the target, or to the den-
sity of antigenic epitopes. Measurement of the affinity of
TCRgd expressed in CD81 and DN CTL clones, and de-
tailed analysis of the target molecules of these gd CTL, are
now needed to clarify these issues.
Most of our sequenced gd CTL clones were found to
have two in-frame TCR g chain transcripts. Further stud-
ies with transgenic mice are needed to determine which in-
frame g chain is responsible for TL recognition, although
surface expression of the Vg2 chain is in doubt (30, 36). It
has been speculated that the TL molecule, a member of the
nonpolymorphic MHC class I molecules, may be recog-
nized by a limited set of TCR (37). However, this seems to
be unlikely since the present analysis showed diversity in
the CDR3 region of g chains, although analysis of d chains is
still necessary. The results suggest heterogeneity in antigenic
epitopes and TL recognition by CTL as discussed below.
Tlaa-3, T3k, and T3b have identical amino acid se-
quences in their PBRs. In their whole proteins, however,
Tlaa-3 and T3b differ at over 30 amino acid positions, while
T3k and T3b are different at a single amino acid position,
276 in the transmembrane region (Fig. 1). T3k expressed in
the intestine of C3H and Tlaa-3 transgenic mice may not
have any significance for the recognition of T3b, since a
previous experiment suggested that T3b expressed in the
intestine does not induce tolerance against T3b itself ex-
pressed in the skin (12). Identification of the antigenic
epitopes recognized by gd and ab CTL against TL should
reveal antigenic determinant(s) responsible for skin graft re-
jection. The CTL against TL were all TL-restricted, re-
gardless of the C3H or Tg.Tlaa-3-2 origin and usage of
TCRab or TCRgd. There are several possible modes in
which CTL can recognize TL molecules. For example,
CTL may recognize a complex of TL and endogenous
peptides, similar to conventional CTL recognition of classi-
cal MHC molecules (38), or a complex of TL and non-
peptide antigens such as CD1 plus lipids (39). CTL may in-
teract with TL molecules without any contribution from
bound peptides, possibly from the side of the TL molecule,
away from the putative PBR of the a1 and a2 domains
(40), or with a complex of TL molecules and peptides de-
rived from TL itself. The CTL may be heterogeneous in
TL recognition; some CTL may recognize TL 1 peptides
while others may recognize TL itself. To determine how
TL molecules are recognized by CTL, the established CTL
clones will be tested further on various TL1 target cells in-
cluding transfectants of Drosophila melanogaster cells express-
ing TL molecules devoid of binding endogenous peptides
(41). Recent studies using a TAP-2–deficient cell line,
RMA-S, have demonstrated that the transport of TL mole-
cules to the cell surface is TAP-2 independent (31, 42), but
these findings do not necessarily exclude the possibility that
TL molecules bind antigenic peptides by other mecha-
nisms. Our previous structural comparison of TL antigens
with classical class I antigens suggested that TL molecules
can form peptide-binding clefts (37). There has been a re-
port that they bind to peptides modified at the amino ter-
mini (43), although an absence of peptides bound to TL has
been also reported (42). The CTL assay is by far the most
sensitive method for detecting antigenic peptides bound to
MHC molecules (44), and its application should allow
more complete elucidation of the function of TL in the
immune system.
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